8-oxo-dG |
M13 phage in E. coli
|
50–90% |
G → T (∼0.5–l%) |
179 |
|
M13 phage in E. coli
|
|
G →T (0.72%) |
178 |
8-oxo-dA |
double-stranded vector in NIH 3T3 cells |
|
A → G + A → C (∼1% in total) |
180 |
Fapy-dG |
single-stranded vector in COS-7 simian kidney cells |
|
G → T (∼8–30%) |
181 |
|
|
|
G → C (∼2%) |
|
Fapy-dA |
single-stranded vector in COS-7 cells |
|
A → C (∼0.4%) |
181 |
dGh |
single-stranded phage in wild-type AB1157 E. coli cells |
∼75 ± 5% |
G → C (98%) |
191 |
|
|
|
G → T (2%) |
|
|
single-stranded M13 phage in AB1157 E. coli cells (with MufY+ or Mut Y−) |
∼20% (MutY+) ∼30% (MutY−) |
for MutY+
E. coli
|
192 |
|
|
|
G → C (∼57%) |
|
|
|
|
G → T (∼40%) |
|
|
|
|
G → A (∼3%) |
|
|
|
|
no significant changes in mutation type or frequency were found in MutY−
E. coli compared to MutY+
E. coli
|
|
dSp |
single-stranded M13 phage in wild-type AB1157 E. coli cells |
stereoisomer 1: ∼9 ± 3% |
stereoisomer 1: |
191 |
|
|
|
G → C (72%) |
|
|
|
|
G → T (27%) |
|
|
|
stereoisomer 2: ∼9 ± 4% |
stereoisomer 2: |
|
|
|
|
G → C (57%) |
|
|
|
|
G → T (41%) |
|
|
single-stranded M13 phage in AB1157 E. coli cells (with MutY+ or MutY−) |
MutY+ strain: <20% for both stereoisomers; MutY− strain: ∼30% for both stereoisomers |
stereoisomer 1 (for MutY+
E. coli): G → C (∼19%) |
192 |
|
|
|
G → T (∼78%) |
|
|
|
|
G → A (∼1%) |
|
|
|
|
stereoisomer 2 (for MutY+
E. coli): |
|
|
|
|
G → C (∼48%) |
|
|
|
|
G → T (∼49%) |
|
|
|
|
G → A (∼3%) |
|
|
|
|
no significant changes in mutation type or frequency were found in MutY−
E. coli compared to MutY+
E. coli
|
|
thymidine glycol |
single-stranded M13 phage in E. coli
|
lethal |
not detectable |
202 |
5-hmdU |
ϕX-174am3 phage in E. coli spheroplasts |
|
not detectable |
214 |
5-fdU |
double-stranded vectors in COS-7 simian kidney cells |
not blocking |
T → G + T → A (0.01–0.04% in total) |
226 |
5-hmdC |
single-stranded M13 phage in E. coli cells |
∼90–110% |
C → G + C → T + C → A (0.17–1.12% in total) |
240 |
|
double-stranded vector in HEK-293T human kidney epithelial cells |
∼100% |
not detectable |
242 |
5-fdC |
single-stranded M13 phage in E. coli cells |
∼90–110% |
C → G + C → T + C → A (0.17–1.12% in total) |
240 |
|
double-stranded vector in COS-7 cells |
39–90% |
C → G + C → T + C → A (0.03–0.28% in total) |
241 |
|
double-stranded vector in HEK-293T cells |
∼70% |
not detectable |
242 |
5-cadC |
single-stranded M13 phage in E. coli cells |
∼ 90–110% |
C → G + C → T + C→A (0.17–1.12% in total) |
240 |
|
double-stranded vector in HEK-293T cells |
∼70% |
not detectable |
242 |
S-cdA |
single-stranded M13 phage in E. coli
|
∼10–31% |
A → T (∼11%) |
253 |
|
double-stranded vector in Pol η-deficient XP30RO cells and Pol η -complemented XP30RO cells |
Pol η -deficient XP30RO cells: ∼3%; Pol η -complemented XP30RO cells: ∼5% |
Pol η-deficient XP30RO cells: A →T (∼S%) Pol η-complemented XP30RO cells: A → T (∼9%) |
254 |
S-cdG |
single-stranded plasmid in E. coli
|
<1% without SOS induction; <5.5% with SOS induction |
G→A+G→T + deletion of 5′C (∼34% in total) |
252 |
|
single-stranded M13 phage in E. coli
|
∼4–11% |
G→A (∼40% without SOS, ∼20% with SOS) |
253 |
|
double-stranded vector in Pol η -deficient XP30RO cells and Pol η -complemented XP30RO cells |
Pol η -deficient XP30RO cells: ∼2%; Pol η -complemented XP30RO cells: ∼4% |
Pol η-deficient XP30RO cells: G→A (∼3%) |
254 |
|
|
|
G →T (∼27%); |
|
|
|
|
Pol η-complemented XP30RO cells: G→A (∼11%) |
|
|
|
|
G →T (∼32%) |
|
d(G[8-S]C) |
single-stranded M13 phage in wild-type AB11S7 E. coli
|
20% |
G →T (8.7%) |
107 |
|
|
|
G→C (1.2%) |
|
d(G[8-Sm]T) |
single stranded pMS2 vector in E. coli (wild type and polymerase-deficient cells) |
without SOS induction: 1.2–25%; with SOS induction: 3.1–35% |
G→T (2.5% without SOS, 6.2% with SOS in wild-type cells) |
258 |
5-Cl-dC |
single-stranded M13 phage in E. coli
|
82–102% |
C → T (∼5%) |
264 |
dNIm |
single stranded M13mp7L2 bacteriophage genome in AB1157 E. coli
|
without SOS induction: 7%; with SOS induction: 57% |
G → C (8.9%) |
272 |
|
|
|
G → A (19%) |
|
|
|
|
G → T (22%) |
|
εdA |
single-stranded pMS2 vector in E. coli and COS-7 cells |
|
in E. coli: very limited mutations; in COS-7 cells: |
275 |
|
|
|
A → G (63%) |
|
|
|
|
A → T (6%) |
|
|
|
|
A → C (1%) |
|
|
single-stranded pMS2 vector and double-stranded pSBK vector in HeLa and HCT116 cells |
|
ssDNA in HeLa cells: |
277 |
|
|
|
A → G (2%) |
|
|
|
|
A → T (8%) |
|
|
|
|
A → C (1%) |
|
|
|
|
dsDNA in HeLa cells (leading strand): |
|
|
|
|
A → G (2%) |
|
|
|
|
A → T (7%) |
|
|
|
|
A → C (5%) |
|
|
|
|
dsDNA in HCT116 cells (leading strand): |
|
|
|
|
A → G (5%) |
|
|
|
|
A → C (2%) |
|
|
|
|
dsDNA in HeLa cells (lagging strand): |
|
|
|
|
A → G (5%) |
|
|
|
|
A → T (4%) |
|
|
|
|
A → C (1%) |
|
|
double-stranded M13mp2SVoriL vectors in E. coli
|
|
A → C (1.6 X (10−4) |
276 |
|
|
|
A → G (2.9 X (10−4) |
|
|
|
|
A → T (2.0 X 10−4) |
|
εdC |
single-stranded pMS2 vector in E. coli or COS-7 cells |
|
uninduced E. coli cells: C → A + C → T (2% in total) |
278 |
|
|
|
SOS-induced cells: C → A + C → T (32% in total) |
|
|
|
|
COS-7 cells: C → A + C → T (81% in total) |
|
l,N2-εdG |
single-stranded M13MB19 phage in uvrA−
E. coli
|
|
G → A (2.05%) |
279 |
|
|
|
G → T (0.74%) |
|
|
|
|
G → C (0.09%) |
|
N2,3-εdG |
single-stranded M13G*1 phage in E. coli
|
|
G → A (0.5%) |
280 |
M1G |
doubled stranded M13MB102 phage in wild-type LM102 cells E. coli cells |
20% for the (–)-strand |
G → A (0.35%) |
284 |
|
|
|
G → T (0.4%) |
|
|
|
|
G → C (0.12%) |
|
|
single-stranded pS189 vector and double-stranded M13MB102-1 vector in E. coli and COS-7 cells |
|
−1 or −2 frameshift in E. coli and COS-7 with reiterated (CpG)4 sequence (≤1% in total) G→A+G → T + G → C (≤2% in total) |
286 |